Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Inogen, Inc. (INGN) Cash Flow Statement

Inogen, Inc. (INGN) generated -$2.5M of operating cash flow over the twelve months to 2026-06-30, spent $7.2M on capital expenditure and had free cash flow of -$9.7M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INGNInogen, Inc.Follow INGN — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
188.4M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2014
Dec 14
FY2015
Dec 15
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow15.738.231.060.560.040.637.023.6-37.5-3.25.9-11.2-2.5
Capital expenditure1.62.21.72.98.03.14.423.921.226.515.010.4-7.2
Free cash flow14.136.029.357.651.937.532.6-0.3-58.8-29.8-9.1-21.6-9.7
Stock-based compensation1.53.67.39.612.89.18.210.912.37.47.48.0—

USD millions · SEC XBRL

Inogen, Inc. — questions

What is Inogen, Inc.'s operating cash flow?
-$2.5M over the twelve months to 2026-06-30.
How much does Inogen, Inc. spend on capital expenditure?
$7.2M over the twelve months to 2026-06-30.
What is Inogen, Inc.'s free cash flow?
-$9.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Inogen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.